Immix Biopharma Inc. has entered into an At The Market Offering Agreement with Citizens JMP Securities, LLC, allowing the company to offer and sell shares of its common stock at its discretion through the agent. The sales will be conducted under the company's effective Registration Statement on Form S-3. The agent will earn a commission of 3% on the gross sales proceeds and will also be reimbursed for certain specified expenses up to $50,000. The agreement enables Immix Biopharma to strategically sell shares in alignment with market conditions and company requirements.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。